What does an albumin-to-creatinine ratio (ACR) of 94 indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Albumin-to-Creatinine Ratio (ACR) of 94 mg/g Indicates Moderately Increased Albuminuria

An albumin-to-creatinine ratio (ACR) of 94 mg/g indicates moderately increased albuminuria (formerly called microalbuminuria), which is a sign of kidney damage and an independent risk factor for cardiovascular disease and progression of chronic kidney disease (CKD). 1

Classification and Significance

  • ACR values are categorized as follows:

    • Normal to mildly increased: <30 mg/g
    • Moderately increased albuminuria: 30-299 mg/g
    • Severely increased albuminuria: ≥300 mg/g 1, 2
  • At 94 mg/g, this falls clearly within the moderately increased albuminuria range, indicating:

    • Early kidney damage
    • Increased risk for CKD progression
    • Elevated cardiovascular risk independent of other factors 1, 2

Clinical Implications

Risk Assessment

  • According to the KDIGO heatmap, the presence of moderately increased albuminuria increases the risk for CKD progression and cardiovascular events 1
  • The risk level depends on the concurrent estimated glomerular filtration rate (eGFR):
    • With normal eGFR (≥90 ml/min/1.73m²): Moderate risk
    • With reduced eGFR: Higher risk that increases as eGFR declines 1

Confirmation Required

  • A single ACR value of 94 mg/g is not sufficient for diagnosis
  • Confirmation requires 2 out of 3 abnormal specimens collected within a 3-6 month period 2
  • Rule out transient causes of elevated albumin excretion:
    • Exercise within 24 hours
    • Urinary tract infection
    • Marked hyperglycemia
    • Marked hypertension
    • Congestive heart failure
    • Febrile illness 1, 2

Management Recommendations

Blood Pressure Control

  • Target blood pressure <130/80 mmHg 2
  • First-line therapy: ACE inhibitor or ARB
    • Goal: Reduce urinary albumin by ≥30% 2
    • Monitor serum creatinine and potassium within 2-4 weeks of starting or adjusting therapy 2

Glycemic Control

  • Target HbA1c <7% for patients with diabetes 2
  • Consider SGLT2 inhibitor with proven kidney benefit if eGFR ≥20 ml/min/1.73m² 2

Lifestyle Modifications

  • Low-sodium diet (<2g/day)
  • Moderate protein intake (~0.8 g/kg/day)
  • Regular physical activity
  • Smoking cessation
  • Weight management if overweight/obese 2
  • Avoid nephrotoxic medications (NSAIDs, certain antibiotics) 2

Monitoring and Follow-up

Frequency of Monitoring

  • More frequent monitoring (every 3-6 months) is recommended after detection of moderately increased albuminuria 1, 2
  • Monitor for:
    • Changes in ACR
    • Decline in eGFR
    • Development of CKD complications 1, 2

Referral to Nephrologist

  • Consider nephrology referral if:
    • Continuously increasing urinary albumin levels
    • Rapidly declining eGFR
    • eGFR <30 ml/min/1.73m²
    • Uncertainty about the etiology of kidney disease 2

Common Pitfalls to Avoid

  1. Relying on a single measurement: Albuminuria can vary by 40-50% day-to-day; confirmation with repeat testing is essential 1, 2

  2. Using dipstick tests alone: Standard dipstick tests have poor sensitivity (43.6%) for detecting moderately increased albuminuria 3

  3. Ignoring time of collection: First morning void samples are preferred to minimize confounding factors 2

  4. Overlooking non-renal causes: Transient elevations can occur due to exercise, fever, urinary tract infections, and other conditions 1, 2

  5. Focusing only on kidney outcomes: Moderately increased albuminuria is also an independent cardiovascular risk factor that warrants aggressive risk factor management 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Kidney Disease Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.